IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Tomasoni, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.172
AS - Asia 770
EU - Europa 767
SA - Sud America 7
AF - Africa 4
OC - Oceania 4
Totale 2.724
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.165
SG - Singapore 291
IT - Italia 239
HK - Hong Kong 212
DE - Germania 164
FI - Finlandia 133
CN - Cina 121
TR - Turchia 115
IE - Irlanda 67
GB - Regno Unito 50
UA - Ucraina 31
CZ - Repubblica Ceca 30
SE - Svezia 13
IN - India 12
FR - Francia 10
BE - Belgio 7
JP - Giappone 7
NL - Olanda 7
CA - Canada 5
ES - Italia 4
PL - Polonia 4
BR - Brasile 3
PH - Filippine 3
AU - Australia 2
KZ - Kazakistan 2
MX - Messico 2
NZ - Nuova Zelanda 2
PE - Perù 2
RU - Federazione Russa 2
TN - Tunisia 2
VE - Venezuela 2
VN - Vietnam 2
ZA - Sudafrica 2
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
EE - Estonia 1
HR - Croazia 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
Totale 2.724
Salva come PNG Salva come JPEG
Città #
Singapore 225
Hong Kong 211
Chandler 138
Ashburn 136
Helsinki 114
Istanbul 110
Fairfield 102
Princeton 75
New York 69
Beijing 68
Dublin 67
Romola 55
Frankfurt am Main 41
Woodbridge 40
Houston 36
Wilmington 34
Cambridge 32
Seattle 32
Shanghai 32
Brescia 27
Brno 26
Jacksonville 26
Munich 24
Milan 23
Ann Arbor 22
Lappeenranta 15
Washington 15
Los Angeles 13
Kilburn 12
London 8
Brussels 7
Pune 6
Strasbourg 6
Trieste 6
West Jordan 6
Curno 4
Espoo 4
Olomouc 4
Rome 4
San Diego 4
Venice 4
Acton 3
Airola 3
Azzano San Paolo 3
Chicago 3
Chiswick 3
Des Moines 3
Eindhoven 3
Falkenstein 3
Leipzig 3
Lviv 3
Matera 3
Nantes 3
North Bergen 3
Potsdam 3
Prescot 3
Quezon City 3
San Francisco 3
São Paulo 3
Tokyo 3
Toronto 3
Verona 3
Bagnoli del Trigno 2
Bari 2
Bergamo 2
Berlin 2
Bernareggio 2
Boardman 2
Cape Town 2
Changsha 2
Chennai 2
Christchurch 2
Codigoro 2
Conegliano 2
Costa Masnaga 2
Fujinomiya 2
Gavardo 2
Gijón 2
Guangzhou 2
Hamburg 2
Hangzhou 2
Ho Chi Minh City 2
Hounslow 2
Kitamachi 2
Kocaeli 2
Lima 2
Lodz 2
Meda 2
Melbourne 2
Miami 2
Miranda 2
Montesilvano Marina 2
Nanjing 2
Newark 2
Olginate 2
Padova 2
Palermo 2
Pisogne 2
Prineville 2
Rockville 2
Totale 2.022
Salva come PNG Salva come JPEG
Nome #
August 2020 at a glance: focus on neurohormonal antagonists and electrolytes 103
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 79
Review: Evidence-Based Management of Acute Heart Failure 69
Highlights in heart failure 67
Acute heart failure: More questions than answers 66
Clinical characteristics and outcome of acute heart failure patients with mid-range ejection fraction. 63
In-hospital and long-term mortality for acute heart failure: analysis at the time of admission to the emergency department 59
COVID 19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease 57
Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study 54
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) 43
Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors 40
Direct Oral Anticoagulants for the Treatment of Left Ventricular Thrombus-A New Indication? A Meta-summary of Case Reports. 40
September 2020 at a glance: focus on heart failure with preserved ejection fraction and medical therapy 40
July 2020 at a glance: focus on imaging and cardiomyopathies 40
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 38
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study) 38
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 34
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 34
Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta-blockers in patients hospitalized for acute heart failure 34
Prediction of mortality and heart failure hospitalisations in patients undergoing M-TEER: external validation of the COAPT risk score 33
Heart failure in the last year: progress and perspective 32
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 32
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 32
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study 31
Congestion in Patients with Advanced Heart Failure: Assessment and Treatment 31
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 31
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 30
Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversy 29
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 28
March 2023 at a glance: pathophysiology, medical therapy and devices 28
Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarction 28
Updates in heart failure: sodium glucose co-transporter 2 inhibitors and beyond - major changes are coming 28
[Empagliflozin and heart failure: the EMPEROR-Reduced trial] 27
A year in heart failure: an update of recent findings 27
COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae 26
The prognostic value of serial troponin measurements in patients admitted for COVID-19 26
April 2022 at a glance: focus on prevention, acute heart failure and heart failure with preserved ejection fraction 25
Impact of Transcatheter Edge-to-Edge Mitral Valve Repair on Guideline-Directed Medical Therapy Uptitration 25
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction? 25
Prognostic significance of serum potassium in patients hospitalized for acute heart failure 24
August 2021 at a glance: focus on cardiomyopathies, medical treatment and devices 24
[Transcatheter devices for chronic heart failure: state of the art] 24
Aiming at harmony. Comparing and contrasting International HFrEF Guidelines 23
[Sodium-glucose cotransporter 2 inhibitors and heart failure with preserved ejection fraction: the EMPEROR-Preserved and DELIVER studies] 23
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 23
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 22
Prognostic value of right ventricular longitudinal strain in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair 21
Myocardial Involvement in COVID-19: an Interaction Between Comorbidities and Heart Failure with Preserved Ejection Fraction. A Further Indication of the Role of Inflammation 21
Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonists 21
August 2022 at a glance: focus on heart failure with preserved ejection fraction and cardiac amyloidosis 21
Sacubitril/valsartan in real-life European patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis 21
Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction 20
Coronavirus disease 2019 and cardiovascular disease: what we have learnt during the last 2 years 20
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 20
January 2023 at a glance: focus on acute heart failure and medical therapy 20
Impact and predictors of device-related thrombus after percutaneous left atrial appendage closure 20
Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation 19
Value of the HFA-PEFF and H2 FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 18
Telemedicine for the treatment of heart failure: new opportunities after COVID-19 17
October 2022 at a glance: focus on clinical trials 17
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 17
Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk 17
Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HF 16
2024 update in heart failure 16
Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry 16
April 2023 at a glance: focus on diagnosis and comorbidities 15
June 2023 at a glance: focus on worsening heart failure, heart failure with preserved ejection fraction and valvular heart disease 15
2023 focused update of the 2021 ESC heart failure guidelines: Key messages for clinical practice 15
December 2020 at a glance: focus on COVID-19, comorbidities and palliative care 14
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 14
Addressing comorbidities in heart failure: When feeling better and living longer go in the same direction 14
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial 14
Heart failure: an update from the last years and a look at the near future 14
July 2022 at a glance: focus on prognosis, devices and valvular heart disease 14
November 2020 at a glance: focus on comorbidities and medical treatment 14
Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials 13
Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis 13
Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failure 13
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology 13
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 13
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials 13
Prognostic Benefit of New Drugs for HFrEF: A Systematic Review and Network Meta-Analysis 13
January 2022 at a glance: time for the new ESC guidelines on heart failure 12
January 2021 at a glance: focus on sex differences, acute heart failure and exercise capacity 12
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 12
Outcome and Morphofunctional Changes on Cardiac Magnetic Resonance in Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination 12
Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction 12
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy 11
May 2023 at a glance: focus on pathophysiology, comorbidities and devices 11
Coronary artery disease: novel insights in a long-standing disease 11
The Mayo ATTR-CM score versus other diagnostic scores and cardiac biomarkers in patients with suspected cardiac amyloidosis 11
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 11
November 2021 at a glance: focus on prevention, comorbidities, cardiogenic shock and novel devices 11
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial 11
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 11
June 2022 at a glance: prevention, outcomes and treatment 11
July 2021 at a glance: focus on blood volume distribution, haemodynamics and adherence to therapy 11
Device-based percutaneous treatments to decompress the left atrium in heart failure with preserved ejection fraction 11
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 10
Sodium-glucose co-transporter 2 inhibitors as an early, first-line therapy in patients with heart failure and reduced ejection fraction 10
Totale 2.528
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.807
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.807
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202024 0 0 0 0 0 1 0 3 1 8 5 6
2020/2021340 12 13 13 23 8 20 89 68 20 38 21 15
2021/2022202 4 41 4 6 8 6 8 10 14 10 18 73
2022/2023486 59 36 8 18 36 137 7 32 73 15 31 34
2023/20241.152 59 13 106 90 74 136 82 23 278 38 43 210
2024/2025608 21 28 95 247 217 0 0 0 0 0 0 0
Totale 2.825